CVS Health Files 8-K on Operations and Personnel
Ticker: CVS · Form: 8-K · Filed: Oct 18, 2024 · CIK: 64803
Sentiment: neutral
Topics: 8-K, operations, personnel
Related Tickers: CVS
TL;DR
CVS filed an 8-K detailing operational results and personnel changes as of Oct 17, 2024.
AI Summary
CVS Health Corporation filed an 8-K on October 18, 2024, reporting on events that occurred on October 17, 2024. The filing covers results of operations, financial condition, departure/election of directors and officers, and includes Regulation FD disclosures and financial statements/exhibits. Specific financial figures or executive changes were not detailed in the provided text.
Why It Matters
This 8-K filing provides updates on CVS Health's operational and financial status, as well as any significant changes in its board or executive team, which are crucial for investors to monitor.
Risk Assessment
Risk Level: low — The filing is a standard 8-K reporting routine corporate events and does not appear to contain immediate negative financial news.
Key Players & Entities
- CVS HEALTH Corp (company) — Registrant
- 0000064803 (company) — Central Index Key
- October 17, 2024 (date) — Earliest event reported
- October 18, 2024 (date) — Filing date
FAQ
What specific results of operations or financial condition changes are being reported by CVS Health?
The provided text indicates that the 8-K covers 'Results of Operations and Financial Condition' but does not specify the details of these results or conditions.
Were there any departures or elections of directors or officers on October 17, 2024?
The filing lists 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' as an item covered, but the specific individuals or changes are not detailed in the provided text.
Does the 8-K filing include any new compensatory arrangements for officers?
The filing mentions 'Compensatory Arrangements of Certain Officers' as a topic, but no specific details about these arrangements are present in the provided excerpt.
What is the significance of the Regulation FD Disclosure mentioned in the filing?
Regulation FD (Fair Disclosure) ensures that material non-public information is disclosed to all investors simultaneously, so this section likely contains information that CVS Health is making public to comply with this regulation.
Are there any exhibits or financial statements attached to this 8-K filing?
Yes, the filing explicitly states 'Financial Statements and Exhibits' as an item covered, indicating that these documents are part of the submission.
Filing Stats: 1,292 words · 5 min read · ~4 pages · Grade level 10.5 · Accepted 2024-10-18 06:46:01
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share CVS New York Stock Exchan
- $375,000 — will receive a monthly advisory fee of $375,000 and continued Company-provided security
Filing Documents
- d837701d8k.htm (8-K) — 32KB
- d837701dex991.htm (EX-99.1) — 31KB
- g837701g1017200902113.jpg (GRAPHIC) — 2KB
- 0001193125-24-239193.txt ( ) — 195KB
- cvs-20241017.xsd (EX-101.SCH) — 3KB
- cvs-20241017_lab.xml (EX-101.LAB) — 17KB
- cvs-20241017_pre.xml (EX-101.PRE) — 11KB
- d837701d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release, dated October 18, 2024 (furnished under Item 7.01). 104 Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document. -2- SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Date: October 18, 2024 CVS HEALTH CORPORATION By: /s/ Kristina V. Fink Name: Kristina V. Fink Title: Senior Vice President, Chief Governance Officer and Corporate Secretary -3-